Onconetix, Inc.
ONCO
$0.81
-$0.03-3.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -20.47% | -92.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.47% | -92.92% | |||
| Cost of Revenue | -44.59% | -58.68% | |||
| Gross Profit | 352.94% | -100.69% | |||
| SG&A Expenses | 10.12% | 35.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.03% | 33.33% | |||
| Operating Income | -7.31% | -63.24% | |||
| Income Before Tax | 31.97% | -174.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.97% | -174.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.97% | -174.34% | |||
| EBIT | -7.31% | -63.24% | |||
| EBITDA | -7.47% | -63.26% | |||
| EPS Basic | 98.09% | -137.10% | |||
| Normalized Basic EPS | -101.70% | -71.24% | |||
| EPS Diluted | 98.09% | -137.10% | |||
| Normalized Diluted EPS | -101.70% | -71.24% | |||
| Average Basic Shares Outstanding | 3,465.66% | 100.32% | |||
| Average Diluted Shares Outstanding | 3,465.66% | 100.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||